Use of mineralocorticoid receptor antagonist in ST elevation myocardial infarction

Muhammad H Khan¹, Myron C Gerson^{2

3}

Affiliations

¹ University of Cincinnati Department of Internal Medicine, Cincinnati, USA.
² University of Cincinnati Department of Cardiovascular Medicine, Cincinnati, USA. gersonml@ucmail.uc.edu.
³ Division of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. gersonml@ucmail.uc.edu.

Editorial

Muhammad H Khan et al. J Nucl Cardiol. 2022 Oct.

. 2022 Oct;29(5):2336-2339.

doi: 10.1007/s12350-021-02801-9. Epub 2021 Sep 13.

Muhammad H Khan¹, Myron C Gerson^{2

3}

¹ University of Cincinnati Department of Internal Medicine, Cincinnati, USA.
² University of Cincinnati Department of Cardiovascular Medicine, Cincinnati, USA. gersonml@ucmail.uc.edu.
³ Division of Cardiovascular Health and Disease, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. gersonml@ucmail.uc.edu.

No abstract available

Comment on

1. Antman E, Anbe D, Armstrong P, Bates E, Green L, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—Executive summary. Circulation 2004;110:588-96. - DOI
1. Toda K, Kasama S, Toyama T, Kasahara M, Kurabayashi M. Effects of mineralocorticoid receptor antagonist eplerenone on cardiac sympathetic nerve activity and left ventricular remodeling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction. J Nucl Cardiol 2021. https://doi.org/10.1007/s12350-021-02733-4 . - DOI - PubMed
1. Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, et al. The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 2001;15:79-87. - DOI
1. Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, et al. Prognostic value of cardiac sympathetic nerve activity evaluated by ^[123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction. Heart 2011;97:20-6 - DOI
1. McGhie A, Corbett J, Akers M, Kulkarni P, Sills M, Kremers M, et al. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 1991;67:236-42. - DOI